Our top pick for
Beginners

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Endava plc is a software-infrastructure business based in the US. Endava shares (DAVA) are listed on the NYSE and all prices are listed in US Dollars. Endava employs 7,199 staff and has a market cap (total outstanding shares value) of USD$5.2 billion.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
52-week range | USD$27.21 - USD$88.62 |
---|---|
50-day moving average | USD$81.2515 |
200-day moving average | USD$67.6796 |
Wall St. target price | USD$6523.9 |
PE ratio | 203.2697 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | USD$0.419 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Endava stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Endava's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Endava's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 203x. In other words, Endava shares trade at around 203x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Gross profit TTM | USD$100.2 million |
---|---|
Return on assets TTM | 8.36% |
Return on equity TTM | 15.7% |
Profit margin | 9.19% |
Book value | $3.75 |
Market capitalisation | USD$5.2 billion |
TTM: trailing 12 months
There are currently 58,167 Endava shares held short by investors – that's known as Endava's "short interest". This figure is 30.9% down from 84,152 last month.
There are a few different ways that this level of interest in shorting Endava shares can be evaluated.
Endava's "short interest ratio" (SIR) is the quantity of Endava shares currently shorted divided by the average quantity of Endava shares traded daily (recently around 103869.64285714). Endava's SIR currently stands at 0.56. In other words for every 100,000 Endava shares traded daily on the market, roughly 560 shares are currently held short.
However Endava's short interest can also be evaluated against the total number of Endava shares, or, against the total number of tradable Endava shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Endava's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Endava shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Endava shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Endava.
Find out more about how you can short Endava stock.
We're not expecting Endava to pay a dividend over the next 12 months.
Over the last 12 months, Endava's shares have ranged in value from as little as $27.21 up to $88.62. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Endava's is 0.923. This would suggest that Endava's shares are less volatile than average (for this exchange).
Endava plc provides technology services for clients in the consumer products, healthcare, logistics, and retail verticals in Europe, Latin America, and North America. It offers technology and digital advisory services for financial services, healthcare, manufacturing, retail and consumer, business and support services, and TMT sectors; IT strategies; business analysis services in payments, financial services, asset and wealth management, insurance, telecommunications, and digital media areas; program management services; digital product strategy services; and architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services. The company also engages in the identifying, defining, and embedding collaborative data and analytics; and provision of automated testing, cloud native software engineering, continuous delivery, distributed agile delivery, intelligent automation, secure development, agile applications management, cloud infrastructure, DevSecOps, service delivery, smart desk, and telemetry and monitoring services. The company was founded in 2000 and is headquartered in London, United Kingdom.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.